ECONOMIC BURDEN OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) IN A COMMERCIALLY INSURED POPULATION IN THE UNITED STATES

被引：1
|
作者：
Oglesby, A. K. [1 ]
Durden, E. [2 ]
Narayanan, S. [3 ]
Juneau, P. [4 ]
Wilson, K. [5 ]
机构：
[1] GlaxoSmithKline, Res Triangle Pk, NC USA
[2] Truven Hlth, Austin, TX USA
[3] IPSOS, Columbia, MD USA
[4] Truven Hlth Analyt, Bethesda, MD USA
[5] Truven Hlth Analyt, Cambridge, MA USA
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 03期
关键词：
D O I：
10.1016/j.jval.2013.03.607
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A126 / A126
页数：1
相关论文
共 50 条
  • [1] Economic Burden of Systemic Lupus Erythematosus Flares and Comorbidities in a Commercially Insured Population in the United States
    Narayanan, Siva
    Wilson, Kathleen
    Ogelsby, Alan
    Juneau, Paul
    Durden, Emily
    [J]. JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2013, 55 (11) : 1262 - 1270
  • [2] The Economic Burden of Systemic Lupus Erythematosus (SLE) within a Commercially-Insured Population in the United States Stratified By Disease Severity
    Clarke, Ann E.
    Kabadi, Shaum
    Durden, Emily
    Winer, Isabelle
    Bacani, Kirstin
    Costenbader, Karen
    Yazdany, Jinoos
    [J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [3] Economic Burden of Systemic Lupus Erythematosus by Flare Severity in a Commercially Insured Population in the United States.
    Narayanan, Siva
    Durden, Emily
    Oglesby, Alan
    Juneau, Paul
    Wilson, Kathleen L.
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S405 - S405
  • [4] The economic burden of systemic lupus erythematosus in commercially- and medicaid-insured populations in the United States
    Clarke, Ann E.
    Yazdany, Jinoos
    Kabadi, Shaum M.
    Durden, Emily
    Winer, Isabelle
    Griffing, Kirstin
    Costenbader, Karen H.
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 2020, 50 (04) : 759 - 768
  • [5] Economic Burden of HIV in a Commercially Insured Population in the United States
    Chen, Cindy Y.
    Donga, Prina
    Campbell, Alicia K.
    Taiwo, Babafemi
    [J]. JOURNAL OF HEALTH ECONOMICS AND OUTCOMES RESEARCH, 2023, 10 (01): : 10 - 19
  • [6] Economic burden of sarcoidosis in a commercially-insured population in the United States
    Rice, J. Bradford
    White, Alan
    Lopez, Andrea
    Conway, Alexandra
    Wagh, Aneesha
    Nelson, Winnie W.
    Philbin, Michael
    Wan, George J.
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (10) : 1048 - 1055
  • [7] Economic Burden among Commercially Insured Patients with Systemic Sclerosis in the United States
    Zhou, Zhou
    Fan, Yanni
    Tang, Wenxi
    Liu, Xinyue
    Thomason, Darren
    Zhou, Zheng-Yi
    Macaulay, Dendy
    Fischer, Aryeh
    [J]. JOURNAL OF RHEUMATOLOGY, 2019, 46 (08) : 920 - 927
  • [8] Direct Medical Cost Associated with Organ System Involvement in a Commercially Insured Population with Systemic Lupus Erythematosus in the United States.
    Oglesby, Alan
    Durden, Emily
    Narayanan, Siva
    Juneau, Paul
    Wilson, Kathleen L.
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S405 - S406
  • [9] The Economic Burden of Spinal Muscular Atrophy Patients in a Commercially-Insured Population in the United States
    Goble, Joseph
    Dai, Dong
    Boulos, Fernanda
    Weng, Anni
    Johnson, Kristen
    [J]. NEUROLOGY, 2019, 92 (15)
  • [10] Economic burden of interstitial lung disease in a commercially insured population with Sjogren syndrome in the United States
    Lee, Tsung-Ying
    Slejko, Julia F.
    Davies-Teye, Bernard Bright
    Onukwugha, Eberechukwu
    [J]. JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2022, 28 (07): : 786 - 794
12345